SK-N-DZ細胞 
	
		細胞類型:	其他細胞類型
	
	
		是否是腫瘤細胞:	1
	
	
		物種來源:	人
	
	
		器官來源:	大腦
	
	
		運輸方式:	凍存運輸
	
	
		細胞形態:	上皮樣
	
	
		年限:	2 years
	
	
		ATCC Number:	CRL-2149?
	
	
		相關**:	神經母細胞瘤
	
	
		生長狀態:	貼壁生長
	
	
		數量:	大量
	
	
		SK-N-DZ細胞Designations:	SK-N-DZ
	
	
		Depositors:	 C Helson
	
	
		Biosafety Level:	1
	
	
		Shipped:	frozen
	
	
		Medium & Serum:	See Propagation
	
	
		Growth Properties:	adherent
	
	
		Organism:	Homo sapiens
	
	
		Morphology:	epithelial
	
	
		
	
	
		Source:	Organ: brain
	
	
		Disease: neuroblastoma
	
	
		Derived from metastatic site: bone marrow
	
	
		Cell Type: neuroblast;
	
	
		Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. SK-N-DZ細胞Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
	
	
		Tumorigenic:	Yes
	
	
		DNA Profile (STR):	Amelogenin: X
	
	
		CSF1PO: 12
	
	
		D13S317: 8,11
	
	
		D16S539: 9,11
	
	
		D5S818: 12
	
	
		D7S820: 12,13
	
	
		THO1: 6,9
	
	
		TPOX: 8
	
	
		vWA: 16,18
	
	
		Cytogenetic Analysis:	modal number = 44, XX; most cells were monosomic for chromosomes 10, 11, 13, 14 and 19; all cells were missing both copies of chromosome 2; five marker chromosomes of unknown origin were observed in each cell. One of the marker chromosomes contains a homogeneously staining region (HSR); no double minutes were seen
	
	
		SK-N-DZ細胞Age:	2 years
	
	
		Gender:	female
	
	
		Ethnicity:	Caucasian
	
	
		Comments:	SK-N-DZ is a neuroblastoma cell line derived in 1978 from a bone marrow metastasis from a child with poorly differentiated embryonal neuroblastoma.
	
	
		Retinoic acid induces differentiation in this line.
	
	
		Expression of the N-myc gene product was reduced in differentiated SK-N-DZ cells as compared with undifferentiated cells.
	
	
		Expression of the c-src gene product, pp60c-src was enhanced in differentiated SK-N-DZ cells as was tyrosine phosphorylation of cellular proteins.
	
	
		The cells exhibit moderate MDR1 expression.
	
	
		Propagation:	ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium:
	
	
		O.1 mM Non-Essential Amino Acids (NEAA)
	
	
		fetal bovine serum to a final concentration of 10%
	
	
		
	
	
		Temperature: 37.0°C
	
	
		Subculturing:	Protocol:
	
	
		Remove and discard culture medium.
	
	
		Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor.
	
	
		Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
	
	
		Note: SK-N-DZ細胞To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37?C to facilitate dispersal.
	
	
		Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
	
	
		Add appropriate aliquots of the cell suspension to new culture vessels.
	
	
		Incubate cultures at 37?C.
	
	
		
	
	
		Subcultivation Ratio: A subcultivation ratio of 1:4 is recommended
	
	
		Medium Renewal: Every 2 to 3 days
	
	
		Preservation:	Freeze medium: Complete growth medium, 95%; DMSO, 5%
	
	
		Storage temperature: liquid nitrogen vapor phase
	
	
		Related Products:	Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002
	
	
		recommended serum:ATCC 30-2020
	
	
		References:	22290: Sugimoto T, et al. Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies. J. Natl. Cancer Inst. 73: 51-57, 1984. PubMed: 6610792
	
	
		22439: Iavarone A, et al. Uptake and storage of m-iodobenzylguanidine are frequent neuronal functions of human neuroblastoma cell lines. Cancer Res. 53: 304-309, 1993. PubMed: 8417824
	
	
		23127: Matsumoto M, et al. SK-N-DZ細胞Expression of proto-oncogene products during drug-induced differentiation of a neuroblastoma cell line SK-N-DZ. Acta Neuropathol. 79: 217-221, 1989. PubMed: 2480694